Markus Hutterer Selected Research

Markus Hutterer Research Topics

Disease

17	Glioma (Gliomas) 06/2022 - 06/2006
9	Neoplasms (Cancer) 03/2024 - 01/2008
4	Brain Neoplasms (Brain Tumor) 06/2022 - 03/2013
4	Glioblastoma (Glioblastoma Multiforme) 03/2016 - 01/2014
3	Neoplasm Metastasis (Metastasis) 04/2018 - 08/2008
2	Disease Progression 06/2015 - 05/2014
1	Oligodendroglioma 06/2022
1	Astrocytoma (Pilocytic Astrocytoma) 06/2022
1	Movement Disorders (Movement Disorder) 08/2021
1	Lymphoma (Lymphomas) 07/2019
1	Cerebral Hemorrhage 01/2019
1	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2017
1	Cerebral Toxoplasmosis 12/2017
1	Seizures (Absence Seizure) 01/2017
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2017
1	Hypertension (High Blood Pressure) 03/2016
1	Ischemia 03/2014
1	Brain Edema (Cerebral Edema) 04/2013
1	Melanoma (Melanoma, Malignant) 08/2008
1	Ovarian Neoplasms (Ovarian Cancer) 08/2008

Drug/Important Bio-Agent (IBA)

4	Amino Acids FDA Link 12/2017 - 01/2014
4	Tyrosine (L-Tyrosine)FDA Link 12/2017 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 06/2018 - 01/2008
3	LigandsIBA 06/2018 - 01/2008
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2022 - 11/2020
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2018 - 01/2008
2	(18F)fluoroethyltyrosineIBA 12/2017 - 01/2017
2	Temozolomide (Temodar)FDA LinkGeneric 03/2016 - 04/2015
2	Bevacizumab (Avastin)FDA Link 03/2016 - 05/2014
1	Protons (Proton)IBA 06/2022
1	alpha-hydroxyglutarateIBA 11/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2020
1	Inositol (Myoinositol)IBA 11/2020
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	68Ga-pentixaforIBA 04/2018
1	UbiquitinIBA 04/2018
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 03/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2016
1	Biomarkers (Surrogate Marker)IBA 06/2015
1	Prostaglandins BIBA 05/2014
1	Retinaldehyde (Retinal)IBA 03/2014
1	alovudineIBA 01/2014
1	tyrosine receptor (receptor, tyrosine)IBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Sunitinib (Sutent)FDA Link 01/2014
1	NucleosidesIBA 01/2014
1	2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA 01/2011
1	TabletsIBA 01/2011
1	Monoclonal AntibodiesIBA 08/2008
1	Neuregulin-1 (Neuregulin 1)IBA 08/2008
1	ErbB Receptors (EGF Receptor)IBA 08/2008
1	ElementsIBA 01/2008
1	Messenger RNA (mRNA)IBA 01/2008
1	ParaffinIBA 01/2008

Therapy/Procedure

7	Therapeutics 03/2024 - 06/2006
2	Immunotherapy 08/2021 - 07/2019
2	Radiotherapy 03/2016 - 04/2013
1	Palliative Care (Palliative Therapy) 11/2019
1	Combined Modality Therapy 06/2015
1	Chemoradiotherapy 04/2015
1	Drug Therapy (Chemotherapy) 08/2008